Type 2 Diabetes Trial, Recruiting (NCT07079189)

Type 2 Diabetes Trial, Recruiting NCT07079189 Sponsor: Region Skane Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07079189 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with type 2 diabetes
People whose diabetes diagnosis is supported by past medical records or by having previously been prescribed diabetes medication
People aged 35 years or older
People who have access to the internet
People who are willing to give their informed consent to participate

Who may not be able to join:

People who are currently being treated with insulin
People whose diabetes medication has been changed within the three months before joining the trial
People who are already taking part in another study that could affect the results of this trial
People whose health condition or current treatment is considered by the trial investigator to make participation unsuitable (confirm with trial site)
People who are unable to read and write in Swedish
People who work in areas considered to be competing with the trial's interests (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anders Rosengren, MD PhD, Region Skane

Phone: +46705316704

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07079189

Sponsor: Region Skane

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: +46705316704

More information: https://clinicaltrials.gov/study/NCT07079189

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with type 2 diabetes
People whose diabetes diagnosis is supported by past medical records or by having previously been prescribed diabetes medication
People aged 35 years or older
People who have access to the internet
People who are willing to give their informed consent to participate

Who may not be able to join:

People who are currently being treated with insulin
People whose diabetes medication has been changed within the three months before joining the trial
People who are already taking part in another study that could affect the results of this trial
People whose health condition or current treatment is considered by the trial investigator to make participation unsuitable (confirm with trial site)
People who are unable to read and write in Swedish
People who work in areas considered to be competing with the trial's interests (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Region Skane

Registry

ClinicalTrials.gov

Start date

11 August 2025

Est. completion

31 May 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Change of long-term blood glucose concentration measured as glycated hemoglobin at 1 year

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov